<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is a <z:hpo ids='HP_0011010'>chronic</z:hpo> benign disease leading to recurrent <z:hpo ids='HP_0000952'>jaundice</z:hpo> and major unconjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> increase that may be toxic after the use of routine medication </plain></SENT>
<SENT sid="1" pm="."><plain>This report aimed at describing the <z:chebi fb="164" ids="38867">anesthetic</z:chebi> approach in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> patient submitted to videolaparoscopic surgery </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: Female patient, 22 years old with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, submitted to videolaparoscopic surgery under general anesthesia with <z:chebi fb="3" ids="44915">propofol</z:chebi>, <z:chebi fb="0" ids="2569">alfentanil</z:chebi>, <z:chebi fb="0" ids="45652">succinylcholine</z:chebi>, atracurium and <z:chebi fb="0" ids="6015">isoflurane</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>There were no evidences of toxicity during anesthesia </plain></SENT>
<SENT sid="4" pm="."><plain>Postoperative recovery was satisfactory and patient was discharged three days later </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> patients may be safely submitted to general anesthesia without toxicity, provided factors leading to glucuronosyltransferase activity decrease are avoided </plain></SENT>
</text></document>